Who makes ACTs?
Currently there are a few select pharmaceutical companies manufacturing high-quality ACTs. An example is Novartis, the manufacturer of Coartemtm, currently the most widely used combination therapy. This project is not focused on creating a new ACT drug, but will instead develop an alternative source of artemisinin, the key ingredient in ACTs. This product would be sold to other pharmaceutical companies to be incorporated into life-saving treatments. The Artemisinin Project will help ensure that these pharmaceutical companies have a consistent, reliable, and inexpensive source of artemisinin.